214 related articles for article (PubMed ID: 16624575)
1. Recombinant expression and partial characterization of an active soluble histo-aspartic protease from Plasmodium falciparum.
Xiao H; Sinkovits AF; Bryksa BC; Ogawa M; Yada RY
Protein Expr Purif; 2006 Sep; 49(1):88-94. PubMed ID: 16624575
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the monomer-dimer equilibrium of recombinant histo-aspartic protease from Plasmodium falciparum.
Xiao H; Briere LA; Dunn SD; Yada RY
Mol Biochem Parasitol; 2010 Sep; 173(1):17-24. PubMed ID: 20435072
[TBL] [Abstract][Full Text] [Related]
3. Expression and enzymatic characterization of the soluble recombinant plasmepsin I from Plasmodium falciparum.
Xiao H; Tanaka T; Ogawa M; Yada RY
Protein Eng Des Sel; 2007 Dec; 20(12):625-33. PubMed ID: 18073224
[TBL] [Abstract][Full Text] [Related]
4. The catalytic significance of the proposed active site residues in Plasmodium falciparum histoaspartic protease.
Parr CL; Tanaka T; Xiao H; Yada RY
FEBS J; 2008 Apr; 275(8):1698-707. PubMed ID: 18312598
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium falciparum Plasmepsin V (PfPMV): Insights into recombinant expression, substrate specificity and active site structure.
Boonyalai N; Sittikul P; Yuvaniyama J
Mol Biochem Parasitol; 2015 May; 201(1):5-15. PubMed ID: 25986559
[TBL] [Abstract][Full Text] [Related]
6. Prodomain processing of recombinant plasmepsin II and IV, the aspartic proteases of Plasmodium falciparum, is auto- and trans-catalytic.
Kim YM; Lee MH; Piao TG; Lee JW; Kim JH; Lee S; Choi KM; Jiang JH; Kim TU; Park H
J Biochem; 2006 Feb; 139(2):189-95. PubMed ID: 16452306
[TBL] [Abstract][Full Text] [Related]
7. The zymogen of plasmepsin V from Plasmodium falciparum is enzymatically active.
Xiao H; Bryksa BC; Bhaumik P; Gustchina A; Kiso Y; Yao SQ; Wlodawer A; Yada RY
Mol Biochem Parasitol; 2014 Oct; 197(1-2):56-63. PubMed ID: 25447707
[TBL] [Abstract][Full Text] [Related]
8. Expression and purification of a recombinant antibacterial peptide, cecropin, from Escherichia coli.
Xu X; Jin F; Yu X; Ji S; Wang J; Cheng H; Wang C; Zhang W
Protein Expr Purif; 2007 Jun; 53(2):293-301. PubMed ID: 17300953
[TBL] [Abstract][Full Text] [Related]
9. Preparation of recombinant thioredoxin fused N-terminal proCNP: Analysis of enterokinase cleavage products reveals new enterokinase cleavage sites.
Liew OW; Ching Chong JP; Yandle TG; Brennan SO
Protein Expr Purif; 2005 Jun; 41(2):332-40. PubMed ID: 15866719
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of a hemoglobin degrading aspartic protease from the malarial parasite Plasmodium vivax.
Sharma A; Eapen A; Subbarao SK
J Biochem; 2005 Jul; 138(1):71-8. PubMed ID: 16046450
[TBL] [Abstract][Full Text] [Related]
11. Soluble expression of a functionally active Plasmodium falciparum falcipain-2 fused to maltose-binding protein in Escherichia coli.
Goh LL; Loke P; Singh M; Sim TS
Protein Expr Purif; 2003 Dec; 32(2):194-201. PubMed ID: 14965764
[TBL] [Abstract][Full Text] [Related]
12. Expression, purification and activity measurement of soluble BACE protein in E.coli.
Wei XC; Li H; Ji JG; Li R; Ren YF; Feng JH; Hao FY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jul; 34(4):498-501. PubMed ID: 12098775
[TBL] [Abstract][Full Text] [Related]
13. New fusion protein systems designed to give soluble expression in Escherichia coli.
Davis GD; Elisee C; Newham DM; Harrison RG
Biotechnol Bioeng; 1999 Nov; 65(4):382-8. PubMed ID: 10506413
[TBL] [Abstract][Full Text] [Related]
14. Human coproporphyrinogen oxidase. Biochemical characterization of recombinant normal and R231W mutated enzymes expressed in E. coli as soluble, catalytically active homodimers.
Martásek P; Camadro JM; Raman CS; Lecomte MC; Le Caer JP; Demeler B; Grandchamp B; Labbé P
Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):47-58. PubMed ID: 9074788
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium falciparum: biochemical characterization of the cysteine protease falcipain-2'.
Singh N; Sijwali PS; Pandey KC; Rosenthal PJ
Exp Parasitol; 2006 Mar; 112(3):187-92. PubMed ID: 16337629
[TBL] [Abstract][Full Text] [Related]
16. Proteolytic activity of purified avian sarcoma and leukemia virus NC-PR protein expressed in Escherichia coli.
Séllos-Moura M; Vogt VM
Virology; 1996 Jul; 221(2):335-45. PubMed ID: 8661444
[TBL] [Abstract][Full Text] [Related]
17. Parasite killing in Plasmodium vivax malaria by nitric oxide: implication of aspartic protease inhibition.
Sharma A; Eapen A; Subbarao SK
J Biochem; 2004 Sep; 136(3):329-34. PubMed ID: 15598889
[TBL] [Abstract][Full Text] [Related]
18. Expression of a kallikrein-like protease from the snake venom: engineering of autocatalytic site in the fusion protein to facilitate protein refolding.
Hung CC; Chiou SH
Biochem Biophys Res Commun; 2000 Sep; 275(3):924-30. PubMed ID: 10973823
[TBL] [Abstract][Full Text] [Related]
19. Expression and characterization of the recombinant aspartic proteinase A1 from Arabidopsis thaliana.
Mazorra-Manzano MA; Yada RY
Phytochemistry; 2008 Oct; 69(13):2439-48. PubMed ID: 18796341
[TBL] [Abstract][Full Text] [Related]
20. Computational prediction of structure, substrate binding mode, mechanism, and rate for a malaria protease with a novel type of active site.
Bjelic S; Aqvist J
Biochemistry; 2004 Nov; 43(46):14521-8. PubMed ID: 15544322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
